ANALYSIS: The Telecommunications Development Levy – a bugbear of the industry – has been excluded from David Seymour’s ministry’s review.
It was a year of ups and downs; good times, bad times and there were some nasty surprises.
Are investors about to repeat the mistake they made about Ryman Healthcare during the global financial crisis?
Combine seed funding from 40 Maori trusts, taxpayer support from government departments, blueberries and a $30 million capital raise - what do you get?
Shoeshine has heard a lot of anecdotes about Australian investors crowding A2 Milk's share register since the company listed on ASX
When electing new directors most shareholders will read the biographies attached to the voting papers.
NZ-listed company faces a Tijuana challenge — but one analyst says it's underpriced regardless.
Peter Hutson and associates' partial takeover for Abano Healthcare raises a number of questions, not least where the money is coming from.
You've probably heard the expression “commentator's curse” before...
When bubbles burst, the fall-out is usually spectacular.